This study proposes that K2's high adverse effect event is due, not less than in part, to distinctive JWH-018 metabolite exercise with the cannabinoid one receptor (CB1R), and indicates that metabolites of most prescription drugs, but not the carboxy metabolite, retain in vitro As well as in vivo activity at https://eam-220108641.bloggerchest.com/31020789/what-does-eam-2201-mean